Jean-Luc Bodmer

10.5k total citations · 6 hit papers
31 papers, 8.7k citations indexed

About

Jean-Luc Bodmer is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Jean-Luc Bodmer has authored 31 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Immunology and 11 papers in Cancer Research. Recurrent topics in Jean-Luc Bodmer's work include Cell death mechanisms and regulation (15 papers), NF-κB Signaling Pathways (11 papers) and Immune Response and Inflammation (7 papers). Jean-Luc Bodmer is often cited by papers focused on Cell death mechanisms and regulation (15 papers), NF-κB Signaling Pathways (11 papers) and Immune Response and Inflammation (7 papers). Jean-Luc Bodmer collaborates with scholars based in Switzerland, United States and Australia. Jean-Luc Bodmer's co-authors include Pascal Schneider, Jürg Tschopp, Margot Thome, Nils Holler, Kay Hofmann, Kim Burns, Lars E. French, Chantal Mattmann, Michael Hahne and Michael Schröter and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Jean-Luc Bodmer

31 papers receiving 8.6k citations

Hit Papers

Inhibition of death recep... 1997 2026 2006 2016 1997 2000 2002 1997 2000 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhibition of death receptor signals by cellular FLIP
    1997 2.1k citations Martin Irmler, Margot Thome et al. Nature profile →
  2. Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule
    2000 1.5k citations Nils Holler, Margot Thome et al. profile →
  3. The molecular architecture of the TNF superfamily
    2002 706 citations Jean-Luc Bodmer, Pascal Schneider et al. Trends in Biochemical Sciences profile →
  4. TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB
    1997 605 citations Pascal Schneider, Margot Thome et al. Immunity profile →
  5. TRAIL receptor-2 signals apoptosis through FADD and caspase-8
    2000 567 citations Jean-Luc Bodmer, Nils Holler et al. Nature Cell Biology profile →
  6. MyD88, an Adapter Protein Involved in Interleukin-1 Signaling
    1998 532 citations Kimberly Burns, Fabio Martinon et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean-Luc Bodmer Switzerland 23 6.0k 4.3k 2.0k 1.5k 1.1k 31 8.7k
Colin S. Duckett United States 51 6.0k 1.0× 3.5k 0.8× 2.2k 1.1× 2.0k 1.3× 1.1k 1.0× 89 9.7k
Michelle A. Kelliher United States 52 6.8k 1.1× 5.1k 1.2× 2.3k 1.1× 1.6k 1.1× 1.1k 0.9× 95 10.9k
Jürg Tschopp Switzerland 41 5.7k 1.0× 3.3k 0.8× 1.5k 0.7× 1.5k 1.0× 1.0k 0.9× 50 7.7k
Michael Hahne France 41 5.9k 1.0× 5.5k 1.3× 1.7k 0.8× 2.1k 1.4× 950 0.8× 96 10.6k
Hailing Hsu United States 17 4.8k 0.8× 4.2k 1.0× 3.1k 1.5× 1.7k 1.1× 667 0.6× 23 8.3k
Nils Holler Switzerland 20 5.0k 0.8× 3.9k 0.9× 1.5k 0.8× 1.1k 0.8× 917 0.8× 20 8.3k
Peter J. Gough United States 45 6.0k 1.0× 4.4k 1.0× 1.4k 0.7× 1.5k 1.0× 1.2k 1.0× 80 9.6k
Arda Shahinian Canada 29 3.4k 0.6× 6.3k 1.5× 1.5k 0.7× 1.8k 1.2× 792 0.7× 38 9.4k
S.G. Hymowitz United States 40 4.7k 0.8× 3.0k 0.7× 1.1k 0.5× 1.6k 1.0× 718 0.6× 50 7.6k
Steven C. Ley United Kingdom 45 3.9k 0.7× 4.0k 0.9× 1.8k 0.9× 1.4k 0.9× 475 0.4× 83 8.1k

Countries citing papers authored by Jean-Luc Bodmer

Since Specialization
Citations

This map shows the geographic impact of Jean-Luc Bodmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-Luc Bodmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-Luc Bodmer more than expected).

Fields of papers citing papers by Jean-Luc Bodmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-Luc Bodmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-Luc Bodmer. The network helps show where Jean-Luc Bodmer may publish in the future.

Co-authorship network of co-authors of Jean-Luc Bodmer

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-Luc Bodmer. A scholar is included among the top collaborators of Jean-Luc Bodmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-Luc Bodmer. Jean-Luc Bodmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davies, D. Huw, Patrick E. Duffy, Jean-Luc Bodmer, Philip L. Felgner, & Denise L. Doolan. (2015). Large screen approaches to identify novel malaria vaccine candidates. Vaccine. 33(52). 7496–7505. 35 indexed citations
2.
Karczewski, Jakub, Julie Zorman, Su Wang, et al.. (2014). Development of a recombinant toxin fragment vaccine for Clostridium difficile infection. Vaccine. 32(24). 2812–2818. 21 indexed citations
3.
Xie, Jinfu, Julie Zorman, Melanie Horton, et al.. (2013). Development and Optimization of a Novel Assay To Measure Neutralizing Antibodies against Clostridium difficile Toxins. Clinical and Vaccine Immunology. 20(4). 517–525. 12 indexed citations
4.
Bossen, Claudia, Aubry Tardivel, Jean-Luc Bodmer, et al.. (2006). Interactions of Tumor Necrosis Factor (TNF) and TNF Receptor Family Members in the Mouse and Human. Journal of Biological Chemistry. 281(20). 13964–13971. 346 indexed citations
5.
Hopkins-Donaldson, Sally, Pu Yan, Katia Balmas Bourloud, et al.. (2002). Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells. Oncogene. 21(39). 6132–6137. 41 indexed citations
6.
Bodmer, Jean-Luc, Pascal Schneider, & Jürg Tschopp. (2002). The molecular architecture of the TNF superfamily. Trends in Biochemical Sciences. 27(1). 19–26. 706 indexed citations breakdown →
7.
Kaufmann, Markus, Damir Bozic, Christophe Briand, et al.. (2002). Identification of a basic surface area of the FADD death effector domain critical for apoptotic signaling. FEBS Letters. 527(1-3). 250–254. 32 indexed citations
8.
Benedict, Chris A., Paula S. Norris, Theodore I. Prigozy, et al.. (2001). Three Adenovirus E3 Proteins Cooperate to Evade Apoptosis by Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor-1 and -2. Journal of Biological Chemistry. 276(5). 3270–3278. 113 indexed citations
9.
Mühlenbeck, Frank, Pascal Schneider, Jean-Luc Bodmer, et al.. (2000). The Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptors TRAIL-R1 and TRAIL-R2 Have Distinct Cross-linking Requirements for Initiation of Apoptosis and Are Non-redundant in JNK Activation. Journal of Biological Chemistry. 275(41). 32208–32213. 128 indexed citations
10.
Bodmer, Jean-Luc, Nils Holler, Patrizia Vinciguerra, et al.. (2000). TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nature Cell Biology. 2(4). 241–243. 567 indexed citations breakdown →
11.
Holler, Nils, Takao Kataoka, Jean-Luc Bodmer, et al.. (2000). Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors. Journal of Immunological Methods. 237(1-2). 159–173. 40 indexed citations
12.
Hopkins-Donaldson, Sally, et al.. (2000). Loss of caspase-8 expression in neuroblastoma is related to malignancy and resistance to TRAIL-induced apoptosis. Medical and Pediatric Oncology. 35(6). 608–611. 41 indexed citations
13.
Burns, Kimberly, Fabio Martinon, Christoph Esslinger, et al.. (1998). MyD88, an Adapter Protein Involved in Interleukin-1 Signaling. Journal of Biological Chemistry. 273(20). 12203–12209. 532 indexed citations breakdown →
14.
Hahne, Michael, Takao Kataoka, Michael Schröter, et al.. (1998). APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth. The Journal of Experimental Medicine. 188(6). 1185–1190. 431 indexed citations
15.
Thome, Margot, Kay Hofmann, Kim Burns, et al.. (1998). Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Current Biology. 8(15). 885–889. 275 indexed citations
16.
Schneider, Pascal, Jean-Luc Bodmer, Nils Holler, et al.. (1997). Characterization of Fas (Apo-1, CD95)-Fas Ligand Interaction. Journal of Biological Chemistry. 272(30). 18827–18833. 173 indexed citations
17.
Schneider, Pascal, Margot Thome, Kim Burns, et al.. (1997). TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB. Immunity. 7(6). 831–836. 605 indexed citations breakdown →
18.
Bodmer, Jean-Luc, Kim Burns, Pascal Schneider, et al.. (1997). TRAMP, a Novel Apoptosis-Mediating Receptor with Sequence Homology to Tumor Necrosis Factor Receptor 1 and Fas(Apo-1/CD95). Immunity. 6(1). 79–88. 233 indexed citations
19.
Irmler, Martin, Margot Thome, Michael Hahne, et al.. (1997). Inhibition of death receptor signals by cellular FLIP. Nature. 388(6638). 190–195. 2123 indexed citations breakdown →
20.
Higgins, Julian P. T., Jonathan R. Lamb, Susan Tonks, et al.. (1992). Peptide-induced nonresponsiveness of HLA-DP restricted human T cells reactive with Dermatophagoides spp. (house dust mite). Journal of Allergy and Clinical Immunology. 90(5). 749–756. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Colin S. Duckett Breakdown of academic impact, for papers by Michelle A. Kelliher Breakdown of academic impact, for papers by Jürg Tschopp Breakdown of academic impact, for papers by Michael Hahne Breakdown of academic impact, for papers by Hailing Hsu Breakdown of academic impact, for papers by Nils Holler Breakdown of academic impact, for papers by Peter J. Gough Breakdown of academic impact, for papers by Arda Shahinian Breakdown of academic impact, for papers by S.G. Hymowitz Breakdown of academic impact, for papers by Steven C. Ley
Rankless by CCL
2026